Anonymous
Guest
Anonymous
Guest
... labs!
I am pleased to announce more Solstas expansion news. Effective August 3rd, we have acquired Oracle Diagnostic Laboratories (Oracle) of Davie, Florida. This acquisition extends our service network into South Florida and provides an excellent growth opportunity for our company. Oracle is a highly regarded, full-service clinical laboratory with a recent emphasis in the toxicology sector.
The Florida market is a natural growth opportunity for our company and the acquisition of Oracle represents a significant Solstas investment and commitment to healthcare providers in this large state. As with our other recent acquisitions, Oracle is a very good match to our values and culture. They focus on partnership-based client service and building long-lasting customer relationships – both Solstas trademarks. Oracle CEO James Banner and his 100-employee team have continually delivered on their commitments to the South Florida market and, as a result, sport an impressive history of growth. I firmly believe the combination of Oracle and Solstas will create an even more powerful value proposition for the physicians and hospitals in that Florida market. I have no doubt the rich legacy of Oracle will be continued and enhanced through our merger. Personally, I am eager to begin working with James and his outstanding team.
The purchase of Oracle further strengthens our company, stretches our service network and creates new job opportunities for our workforce. As you have observed over the last 8 weeks, we have expanded our presence geographically south and west, aligned with highly respected regional labs and acquired some of the finest talent in the industry. Please join me in welcoming Oracle into the Solstas family and, on a closing note, I hope you share my excitement as we all participate in building a unique laboratory company.
Sincerely,
David Weavil
I am pleased to announce more Solstas expansion news. Effective August 3rd, we have acquired Oracle Diagnostic Laboratories (Oracle) of Davie, Florida. This acquisition extends our service network into South Florida and provides an excellent growth opportunity for our company. Oracle is a highly regarded, full-service clinical laboratory with a recent emphasis in the toxicology sector.
The Florida market is a natural growth opportunity for our company and the acquisition of Oracle represents a significant Solstas investment and commitment to healthcare providers in this large state. As with our other recent acquisitions, Oracle is a very good match to our values and culture. They focus on partnership-based client service and building long-lasting customer relationships – both Solstas trademarks. Oracle CEO James Banner and his 100-employee team have continually delivered on their commitments to the South Florida market and, as a result, sport an impressive history of growth. I firmly believe the combination of Oracle and Solstas will create an even more powerful value proposition for the physicians and hospitals in that Florida market. I have no doubt the rich legacy of Oracle will be continued and enhanced through our merger. Personally, I am eager to begin working with James and his outstanding team.
The purchase of Oracle further strengthens our company, stretches our service network and creates new job opportunities for our workforce. As you have observed over the last 8 weeks, we have expanded our presence geographically south and west, aligned with highly respected regional labs and acquired some of the finest talent in the industry. Please join me in welcoming Oracle into the Solstas family and, on a closing note, I hope you share my excitement as we all participate in building a unique laboratory company.
Sincerely,
David Weavil